The current ILAE-North America region was constituted in 2006, comprising English speaking North American Chapters of Canada, the United States of America, and the English speaking Caribbean (represented by Jamaica). The Mexican chapter, although geographically in North America, is a member of the Latin American Regional Commission.
Our goals and aims are aligned with the ILAE’s emphasis on current and emerging knowledge on epilepsy prevention, diagnosis, treatment, research, and optimal comprehensive epilepsy care.
The Japanese Epilepsy Society has held annual exhibitions of Art Around Epilepsy since 2016 to provide opportunities for people to be exposed to the visual scenes of patients with epilepsy and those involved, as well as to become better acquainted with and gain an accurate understanding of epilepsy. This artwork has now been compiled into a pdf available for free download.
10 April, 2019
New funding opportunity for young trainees and investigators with limited financial resources to attend scientific meetings, workshops or other training opportunities that promise to advance their research career. The bursaries will cover travel expenses to a maximum of $2,000 per applicant to attend a scientific or training activity.
2 April, 2019
Starting ketamine for neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus
We propose that ketamine be started early in the course of human status epilepticus as a neuroprotectant and that it be continued until epileptic discharges are eliminated.
6 March, 2019
The Leadership Development Program is a unique and exclusive opportunity to receive leadership training and network with leaders from around the globe. Session topics include: The Science of Communication, Strategic Planning, Conflict Resolution & Negotiation, Finance, Management Essentials, Assessing and Leveraging Your Leadership Style, Opportunities to Lead within ILAE, and more.
Despite the decrease in the disease burden from 1990 to 2016, epilepsy is still an important cause of disability and mortality. Standardised collection of data on epilepsy in population representative surveys will strengthen the estimates, particularly in countries for which we currently have no or sparse data...
18 February, 2019
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community